PATENT CLAIM ANALYSIS

Application Number: 15757217
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "567000"]

Abstract:
The invention relates to a method of treating a dopamine related disorder in a subject, the method comprises the steps of administering therapy to a subject, the therapy comprising a plurality of doses of levodopa over a selected time period, in combination with a dopamine decarboxylase inhibitor (DDI) and a catechol-O-methyltransferase (COMT) inhibitor, wherein: (i) the dose of levodopa is lower; (ii) the dose of DDI is lower; (iii) the dosing of levodopa is less frequent; and/or (iv) the dosing of DDI is less frequent As compared with a reference regimen over the selected time period.

Claim (Index 24):
The method of any of  claims 18 - 23 , wherein the assessed feature of the test composition is improved at least about 1.5\u00d7, 2.0\u00d7, 2.5\u00d7, 3.0\u00d7, 3.5\u00d7, 4.0\u00d7, 4.5\u00d7, 5.0\u00d7, 5.5\u00d7, 6.0\u00d76.5\u00d7, 7.0\u00d7, 7.5\u00d7, 8.0\u00d7, 8.5\u00d7, 9.0\u00d7, 9.5\u00d7, or 10\u00d7 fold over the reference composition.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 2.08929
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15507959', '14276211', '14276235', '14789214', '12961534']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8273212423459396
- 35 USC 102 Novelty (BERT): 0.5645068980449525
- Combined Prediction Score: 0.801039807915841
- Mean Citation Score: 418.904306
- Max Citation Score: 669.4583
- Similarity Product: 319.93992637748124

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test